Clinical Study

S100A12 and hBD2 Correlate with the Composition of the Fecal Microflora in ELBW Infants and Expansion of E. coli Is Associated with NEC

Table 1

Epidemiological characteristics.

Group with NEC stage ≥2 ( )Control group without any GI problems ( )P value

Gestational age25.4 (24.2–27)25.3 (23.3–27)ns
Birth weight in g747 (650–890)751 (354–990)ns
Umbilical artery pH at birth7.34 (7.26–7.45)7.32 (7.23–7.45)ns
CrP at birth in mg/dL1.52 (0.3–4.32)1.67 (0.2–4.64)ns
Oral feeding day 7 in mL/kg92.4 (50–142)84.9 (50–168)ns
Parenteral fluids day 7 in mL/kg77.6 (21–140)78.8 (0–128)ns
Mean onset of NEC (postnatal day)14.8 (8–28)
Female (N)50% (6)58.9% (33)ns
Delivery per caesarean section (N)91.6% (11)91.1% (51)ns
Antibiotic therapy at day 7 (N)83.3% (10)66% (37)ns
Exclusively breast fed at day 7 (N)16.7% (2)19.6% (11)ns
MEDIAN LOG10 CFU per mg at day 7
 Total Bacterial count8.5 (8.2–10.7)8.7 (7.8–9.1)ns
Lactobacilli 8.1 (7.2–9.0)7.4 (6.9–8.2)<0.01
C. difficile (if positive)7.5 (4.8–11.0)5.9 (5.2–9.6)ns
E. coli 7.0 (6.0–7.6)7.5 (6.6–7.9)<0.05
Bifidobacteria 7.4 (6.1–7.7)7.6 (5.5–7.9)ns
B. fragilis group 6.0 (5.2–6.6)6.0 (5.4–6.7)ns
 Others 7.7 (7.2–10.2)7.9 (6.8–10.9)ns
Prevalence of C. difficile at day 7 (N)33.3% (4)26.8% (15)ns